Tacita Capital’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.1K Hold
300
0.02% 167
2025
Q4
$27K Hold
300
0.02% 169
2025
Q3
$29.6K Hold
300
0.02% 166
2025
Q2
$27.4K Hold
300
0.02% 168
2025
Q1
$34K Hold
300
0.02% 155
2024
Q4
$31.7K Hold
300
0.02% 155
2024
Q3
$32.4K Hold
300
0.02% 153
2024
Q2
$32.6K Hold
300
0.02% 160
2024
Q1
$39.6K Hold
300
0.03% 160
2023
Q4
$36.5K Hold
300
0.03% 159
2023
Q3
$33.7K Hold
300
0.03% 155
2023
Q2
$44K Hold
300
0.03% 146
2023
Q1
$39K Hold
300
0.03% 145
2022
Q4
$38K Hold
300
0.03% 149
2022
Q3
$31K Hold
300
0.02% 154
2022
Q2
$32K Hold
300
0.02% 158
2022
Q1
$38K Sell
300
-9
-3% -$1.08K 0.02% 156
2021
Q4
$38K Hold
309
0.02% 157
2021
Q3
$44K Hold
309
0.03% 150
2021
Q2
$48K Hold
309
0.03% 148
2021
Q1
$48K Hold
309
0.03% 151
2020
Q4
$46K Buy
+309
New +$43.6K 0.03% 152

Other funds holding ZBH

Tacita Capital's ZBH Position: Q1 2026 in Review

Tacita Capital held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 300 shares worth $27.1K. The position accounts for 0.02% of the portfolio, ranked #167.

Tacita Capital first reported a position in ZBH in Q4 2020 and has held it in 22 quarters since. The position peaked at $48K in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Tacita Capital held 300 shares of Zimmer Biomet worth $27.1K as of Q1 2026.
  • Tacita Capital left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up 0.02% of Tacita Capital's portfolio in Q1 2026, its #167 holding.
  • Tacita Capital first reported a position in Zimmer Biomet in Q4 2020 and has held it in 22 quarters since.
  • Tacita Capital's Zimmer Biomet position peaked at $48K in Q2 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Tacita Capital's 13F filing for Q1 2026, filed 7 May 2026.